These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11878049)

  • 21. Hodgkin's lymphoma: evolving concepts with implications for practice.
    Meyer RM; Ambinder RF; Stroobants S
    Hematology Am Soc Hematol Educ Program; 2004; ():184-202. PubMed ID: 15561683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New therapeutic approaches to non-Hodgkin's lymphomas.
    Lambert JF; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma.
    Marcus R
    Semin Oncol; 2005 Feb; 32(1 Suppl 1):S36-43. PubMed ID: 15786024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
    Gisselbrecht C; Vose J; Nademanee A; Gianni AM; Nagler A
    Oncologist; 2009; 14 Suppl 2():41-51. PubMed ID: 19819923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional treatments for non-Hodgkin's lymphoma: the need for new therapies.
    Moskowitz CH
    J Nucl Med; 1998 Aug; 39(8 Suppl):2S-10S. PubMed ID: 9708564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma.
    Brandt L; Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):213-23. PubMed ID: 11441933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to the management of Non-Hodgkin's lymphoma.
    Estes J
    Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):1-2. PubMed ID: 11878045
    [No Abstract]   [Full Text] [Related]  

  • 28. Indications and relative indications for stem cell transplantation in non-Hodgkin's lymphoma.
    Stewart FM
    Leukemia; 1993 Jul; 7(7):1091-4. PubMed ID: 8100601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunotherapy for non-Hodgkin's lymphoma with yttrium 90 ibritumomab tiuxetan.
    Hendrix CS; de Leon C; Dillman RO
    Clin J Oncol Nurs; 2002; 6(3):144-8. PubMed ID: 11998607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New trends in non-Hodgkin's lymphoma therapy].
    Mazur G; Wróbel T; Jurczak W; Butrym A
    Postepy Hig Med Dosw (Online); 2006; 60():707-21. PubMed ID: 17245320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Stone RM; Neuberg D; Soiffer R; Takvorian T; Whelan M; Rabinowe SN; Aster JC; Leavitt P; Mauch P; Freedman AS
    J Clin Oncol; 1994 Dec; 12(12):2535-42. PubMed ID: 7989927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.
    Augustine SC; Norenberg JP; Colcher DM; Vose JM; Gobar LS; Dukat VJ; Hohenstein MA; Rutar FJ; Jacobson DA; Tempero MA
    J Am Pharm Assoc (Wash); 2002; 42(1):93-100. PubMed ID: 11833524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
    Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
    J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
    Younes A; Santoro A; Shipp M; Zinzani PL; Timmerman JM; Ansell S; Armand P; Fanale M; Ratanatharathorn V; Kuruvilla J; Cohen JB; Collins G; Savage KJ; Trneny M; Kato K; Farsaci B; Parker SM; Rodig S; Roemer MG; Ligon AH; Engert A
    Lancet Oncol; 2016 Sep; 17(9):1283-94. PubMed ID: 27451390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
    Newsom-Davis T; Ahamed E; Bower M
    Expert Opin Biol Ther; 2009 Oct; 9(10):1313-24. PubMed ID: 19645631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.